Zynex, Inc. (ZYXI)
| Market Cap | 27.05M |
| Revenue (ttm) | 108.20M |
| Net Income (ttm) | -73.96M |
| Shares Out | 30.39M |
| EPS (ttm) | -2.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 813,560 |
| Open | 1.040 |
| Previous Close | 1.030 |
| Day's Range | 0.840 - 1.060 |
| 52-Week Range | 0.376 - 8.720 |
| Beta | 1.00 |
| Analysts | Hold |
| Price Target | 3.00 (+237.08%) |
| Earnings Date | Nov 17, 2025 |
About ZYXI
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de... [Read more]
Financial Performance
In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for ZYXI stock is "Hold." The 12-month stock price target is $3.0, which is an increase of 237.08% from the latest price.
News
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript
Zynex, Inc. ( ZYXI) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, l...
Zynex Reports Third Quarter 2025 Financial Results
ENGLEWOOD, Colo. , Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee
ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Sets Third Quarter 2025 Earnings Call
ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
ENGLEWOOD, Colo. , Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript
Zynex, Inc. (NASDAQ:ZYXI) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Greg...
Zynex Reports Second Quarter 2025 Financial Results
ENGLEWOOD, Colo. , July 31, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Sets Second Quarter 2025 Earnings Call
ENGLEWOOD, Colo. , July 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Tricare Temporary Payment Suspension Update
ENGLEWOOD, Colo. , July 2, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m...
Zynex Announces Steven Dyson as New CEO
ENGLEWOOD, Colo. , June 30, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, a...
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis
ENGLEWOOD, Colo. , June 25, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain m...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit – ZYXI
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).
Zynex, Inc. (ZYXI) Q1 2025 Earnings Call Transcript
Zynex, Inc. (NASDAQ:ZYXI) Q1 2025 Earnings Conference Call April 29, 2025 4:15 PM ET Company Participants Brian Prenoveau - IR Thomas Sandgaard - Chairman, President and CEO Dan Moorhead - CFO Anna L...
Zynex Reports First Quarter 2025 Financial Results
ENGLEWOOD, Colo. , April 29, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Ne...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit - ZYXI
NEW YORK , April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class perio...
Zynex Sets First Quarter 2025 Earnings Call
ENGLEWOOD, Colo. , April 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...
Wolf Haldenstein Adler Freeman & Herz LLP Announces that SoundHound AI, Inc. has been sued
Law Suit Reveals Misleading Statements Regarding SoundHound AI's Business Operations Law Suit Reveals Misleading Statements Regarding SoundHound AI's Business Operations